Log in to save to my catalogue

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f0f7c08666254d739a6ca421ab557bf3

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

About this item

Full title

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2023-01, Vol.24 (1), p.6-16, Article 6

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial lung disease (ILD) is common in SSc, occurring in 35-52% of patients and accounting for 20-40% of mortality. Evolution of therapeutic options has resulted in a lack of consensus on how to manage this condition. This Delphi study was initiated to develop consensus...

Alternative Titles

Full title

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f0f7c08666254d739a6ca421ab557bf3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f0f7c08666254d739a6ca421ab557bf3

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X

DOI

10.1186/s12931-022-02292-3

How to access this item